SCHEMBL7779503

SCHEMBL7779503

Cc1ccc(-c2c(-c3ccc(S(N)(=O)=O)cc3)nn(Cc3ccccc3)c2C(F)F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 16/20 0.48
PTGS1 P23219 8/20 0.46
CYP2C9 P11712 2/20 0.43
CA12 O43570 3/20 0.43
CA2 P00918 3/20 0.43
CA9 Q16790 3/20 0.43
MT-CO2 P00403 2/20 0.43
CA1 P00915 2/20 0.43
LMNA P02545 2/20 0.43
CA3 P07451 2/20 0.43
CYP3A4 P08684 2/20 0.43
ADORA3 P0DMS8 2/20 0.43
ADRA2B P18089 2/20 0.43
CA4 P22748 2/20 0.43
CA6 P23280 2/20 0.43
SLC6A2 P23975 2/20 0.43
CA5A P35218 2/20 0.43
CA7 P43166 2/20 0.43
CA13 Q8N1Q1 2/20 0.43
CA14 Q9ULX7 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780326 0.91 PTGS2 (0.47) PTGS2PTGS1CYP2C9CA12CA2
SCHEMBL7780143 0.91 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL7779409 0.90 PTGS2 (0.50) PTGS2PTGS1CYP2C9CA12CA2
SCHEMBL7779844 0.87 PTGS2 (0.53) PTGS2PTGS1CYP2C9CA12CA2
SCHEMBL7780783 0.86 PTGS2 (0.56) PTGS2PTGS1CYP2C9CA12CA2
SCHEMBL8628877 0.86 PTGS2 (0.42) PTGS2PTGS1CYP2C9CYP3A4CYP2D6
SCHEMBL7773200 0.83 PTGS2 (0.62) PTGS2PTGS1CYP2C9CA12CA2
SCHEMBL7779765 0.83 PTGS2 (0.53) PTGS2PTGS1PDE4AABCB11PDE4D
SCHEMBL7773087 0.82 PTGS2 (0.48) PTGS2PTGS1CYP2C9CA12CA2
SCHEMBL7779625 0.82 PTGS2 (0.51) PTGS2PTGS1CYP2C9CA12CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed